Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/1998
07/14/1998US5780291 Wnt-x growth factor polypeptide, DNA encoding same, and Wnt-x antibody
07/14/1998US5780286 Arginase II
07/14/1998US5780245 Polypeptides having a serotonin receptor activity, nucleic acids coding for these polypeptides and uses
07/14/1998US5780064 Germicidal compositions for the treatment of animal infectious diseases of the hoof
07/14/1998US5780026 Immunomodulating and antiinflammatory agent
07/14/1998CA2041113C Thienobenzodiazepine derivatives and their use as pharmaceuticals
07/14/1998CA1339954C Dogs - and horse - interferones
07/09/1998WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
07/09/1998WO1998029447A1 Novel human apoptosis regulator
07/09/1998WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response
07/09/1998WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses
07/09/1998WO1998029413A1 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS
07/09/1998WO1998029390A1 Farnesyl transferase inhibitors
07/09/1998WO1998029382A1 Selective inhibitors of prostaglandin endoperoxide synthase-2
07/09/1998WO1998029128A1 Biologically active substances, method for obtaining and compositions containing them
07/09/1998WO1998029124A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein
07/09/1998WO1998029119A1 Inhibitors of farnesyl-protein transferase
07/09/1998WO1998029107A2 Poly(diallylamine)-based bile acid sequestrants
07/09/1998WO1998028980A1 Inhibitors of farnesyl-protein transferase
07/09/1998WO1998021232A3 Mutant forms of fas ligand and uses thereof
07/09/1998CA2278340A1 Novel human apoptosis regulator
07/09/1998CA2278031A1 G-rich oligo aptamers and methods of modulating an immune response
07/09/1998CA2276610A1 3-aryl substituted pyrazolo¬4,3-d|pyrimidine derivatives; corticotropin-releasing factor receptor (crf1) specific ligands
07/09/1998CA2276398A1 Selective inhibitors of prostaglandin endoperoxide synthase-2
07/09/1998CA2276394A1 Poly(diallylamine)-based bile acid sequestrants
07/09/1998CA2276150A1 Inhibitors of farnesyl-protein transferase
07/09/1998CA2276081A1 Inhibitors of farnesyl-protein transferase
07/09/1998CA2275943A1 Farnesyl transferase inhibitors
07/09/1998CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses
07/09/1998CA2239781A1 N-linked ureas and carbamates of heterocyclic thioesters
07/08/1998EP0852225A1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
07/08/1998EP0852144A2 Enhancing keratinocyte migration and proliferation
07/08/1998EP0851929A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS
07/08/1998EP0851925A1 Human growth hormone variants
07/08/1998EP0851875A2 Dna sequences and secreted proteins encoded thereby
07/08/1998EP0851857A1 Inhibitors of tumor necrosis factor alpha
07/08/1998EP0851856A1 Indole derivatives as melatoninergic analogues
07/08/1998EP0851855A1 Acylated derivatives of melatonin and its analogues, useful as medicaments
07/08/1998EP0851769A1 Gene therapy using ovine adenoviral vectors
07/08/1998EP0851760A1 Interleukin converting enzyme and apoptosis
07/08/1998EP0851753A1 Aerosol compositions
07/08/1998EP0851734A1 Capsules containing freeze-dried powdered green tea leaves
07/08/1998EP0820283A4 Lactacystin analogs
07/08/1998EP0788388A4 Device for aerosolized delivery of peptide drugs
07/08/1998EP0777478A4 Inhibitors of rotamase enzyme activity
07/08/1998CN1187203A Method for treatment of corticosteroid induced osteopenia
07/08/1998CN1187188A Small molecule inhibitors of rotamase enzyme activity
07/08/1998CN1187129A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
07/08/1998CN1187128A Phenoxy piperazine derivatives for treating disorders of dopamine system
07/08/1998CN1186808A 10, 13, 15-trioxyheterotricyclo £9, 2, 1, 1, 9, 6|-pentadecanone derivatives, its preparing method and medicine containing it
07/08/1998CN1186692A Yin nourishing, kindney tonifying and yang strengthening wine and its producing method
07/08/1998CN1186664A Folic acid supplementing agent for preventing neural tube deformity
07/08/1998CN1039015C Polyethylene glycol-interferon conjugates
07/08/1998CN1039013C Glucopyranoside benzothiophens compounds and its preparing method and use as medicine
07/08/1998CN1039008C Dual action inhibitors in angiotensin invertase and neutral endopeptidase
07/08/1998CA2226478A1 Nitrogen monoxide production suppressor
07/07/1998US5777176 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/07/1998US5777160 1, 4, 4-(trisubstituted) cyclohex-1-ene dimers and related compounds
07/07/1998US5777125 Process for the preparation of tertiary carbinols containing an amino substituent
07/07/1998US5777114 Spiro heterocycle-imidazo 1,2-a!indeno 1,2-e!pyrazine!-4'-ones, preparation thereof and drugs containing same
07/07/1998US5777081 Process for producing an inter-alpha-trypsin inhibitor concentrate for therapeutic use and concentrate thus obtained
07/07/1998US5776972 Kappa-opiate agonists for inflammatory bowel disorders
07/07/1998US5776968 Therapeutic uses of melanin
07/07/1998US5776964 Hypotensive agents; anticholesterol agents; cardiovascular disorders
07/07/1998US5776958 Antiimflammatory agents and antiasthmatics
07/07/1998US5776951 Anticholesterol agent
07/07/1998US5776949 2-(1H) quinolinone compounds
07/07/1998US5776935 Antagonists of strychnine-insensitive glycine site of n-methylaspartic acid receptor
07/07/1998US5776925 Texaphyrins
07/07/1998US5776919 Potentiators of antimicrobial activity
07/07/1998US5776906 Method for promoting fat-degradation in fat cells
07/07/1998US5776750 Amino acid sequences and polypeptides for hybridizing and genes
07/07/1998US5776731 DNA encoding type-I interleukin-I receptor-like protein designated 2F1
07/07/1998US5776499 Process for preparing a clodronate preparation
07/07/1998US5776464 Administering heptocyte growth factor
07/07/1998US5776442 Catechin compounds
07/07/1998US5776095 Pretargeting noncanerous cells or tissues with a cytoprotective agents before therapy with radiation or anticarcinogenic agents
07/07/1998US5776094 Method and kit for imaging and treating organs and tissues
07/07/1998US5776093 Method for imaging and treating organs and tissues
07/07/1998CA2133963C Novel mercaptoacetylamido pyridazo¬1,2|pyridazine, pyrazolo¬1,2|pyridazine, pyridazo¬1,2-a|¬1,2|diazepine and pyrazolo¬1,2-a|¬1,2|diazepine derivatives useful as inhibitors of enkephalinase and ace
07/07/1998CA2056467C Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations
07/07/1998CA1339947C Peptide compounds
07/02/1998WO1998028621A1 Vegf-b/receptor complex and uses thereof
07/02/1998WO1998028445A1 Recombinant n-smases and nucleic acids encoding same
07/02/1998WO1998028427A1 Ob fusion protein compositions and methods
07/02/1998WO1998028334A1 Peptide antagonists of dp transcription factors
07/02/1998WO1998028330A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
07/02/1998WO1998028327A1 New use of dipeptide derivatives
07/02/1998WO1998028323A1 Meiosis regulating compounds
07/02/1998WO1998028304A1 Pro-drugs and counterparts of camptothecin, their application as medicines
07/02/1998WO1998028300A1 Triazolo[4,5-d]pyrimidinyl derivatives and their use as medicaments
07/02/1998WO1998028295A1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function
07/02/1998WO1998028293A1 Indane or dihydroindole derivatives
07/02/1998WO1998028292A1 Novel piperidine containing compounds
07/02/1998WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
07/02/1998WO1998028276A1 Triarylethanes useful as pde iv inhibitors
07/02/1998WO1998028274A1 Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
07/02/1998WO1998028269A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
07/02/1998WO1998028268A2 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS
07/02/1998WO1998028265A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase